BioMerieux SA Stock Xetra
Equities
EYW
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.18B 5.71B | Sales 2025 * | 4.19B 4.49B 6.14B | Capitalization | 10.49B 11.23B 15.36B |
---|---|---|---|---|---|
Net income 2024 * | 465M 498M 681M | Net income 2025 * | 527M 564M 772M | EV / Sales 2024 * | 2.65 x |
Net cash position 2024 * | 153M 164M 224M | Net cash position 2025 * | 400M 428M 586M | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
20.3
x | Employees | - |
Yield 2024 * |
1% | Yield 2025 * |
1.17% | Free-Float | 36.23% |
Latest transcript on BioMerieux SA
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-0.19% | 5.31B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B | |
-19.12% | 1.57B |